The central government on Monday asked the Serum Institute and Bharat Biotech to lower price of their COVID-19 vaccines amid criticism from various states who accused the companies of profiteering during such a major crisis.
The issue of vaccine pricing was discussed at a meeting chaired by Cabinet Secretary Rajiv Gauba.
Now the two companies are expected to come up with revised pricing for their vaccines.
The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals.
The Pune-based Serum Institute of India (SII), the world’s largest vaccine maker in terms of volume, has announced a price of Rs 400 per dose for its COVID-19 vaccine, ‘Covishield’, for state governments and Rs 600 per dose for private hospitals.
Both vaccines are available to the central government at a rate of Rs 150 per dose.
The Centre has relaxed its vaccination strategy in the third phase under which the country’s large 18-plus population will get inoculated from May 1.